Last reviewed · How we verify
NCT03605407
Patients Visit Prior to Hospital Admission & Intensive Care Unit
NA trial testing Patient visit prior to hospital admission in Anxiety in 38 participants. Completed in 25 January 2019.
20 January 2019
Quick facts
| Lead sponsor | Universidad de León |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | health services research |
| Enrollment | 38 |
| Start date | 22 August 2018 |
| Primary completion | 20 January 2019 |
| Estimated completion | 25 January 2019 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Patient visit prior to hospital admission
Conditions studied
- Anxiety — all drugs for Anxiety →
- Depression — all drugs for Depression →
- Intensive Care Unit Syndrome — all drugs for Intensive Care Unit Syndrome →
Sponsor
Universidad de León
Who can join
18 and older, any sex, with Anxiety or Depression. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The present study evaluates the effects of the visit prior to hospital admission on anxiety, depression and satisfaction of patients in an intensive care unit.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effects of a visit prior to hospital admission on anxiety, depression and satisfaction of patients in an intensive care unit.
González-Martín S, Becerro-de-Bengoa-Vallejo R, Angulo-Carrere MT, Iglesias ME, et al · · 2019 · cited 7× · PMID 31358482 · DOI 10.1016/j.iccn.2019.07.001
Verify or expand the search:
- PubMed search for NCT03605407
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Anxiety
Currently open trials in the same condition.
- NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
- NCT07522944 — AI-Guided Relaxation for Hemodialysis Anxiety · NA · recruiting
- NCT07466875 — Auricular Stimulation for Nicotine Withdrawal in Psychiatric Inpatients · NA · recruiting
- NCT07425951 — Building Cognitive Behavioural Skills With StoryBooks to Reduce Emotional Difficulties in Kindergarten Years · NA · recruiting
- NCT07473505 — Integrative Bilateral Cervical Sympathetic Blocks for Trauma-Related Symptoms in Special Operations Veterans: A Prospect · recruiting
Other Universidad de León trials
Trials by the same sponsor.
- NCT06689631 — Mucociliary Clearance Techniques for Acute Bronchiolitis · NA · not yet recruiting
- NCT06739694 — Neuroscience Education in Shoulder Pain: Clinical Trial · NA · completed
- NCT05860426 — Confidence in the Ability to Perform Movements in Patients With Low Back Pain · completed
- NCT05301400 — Marginal Bone Loss in Single Implant Restaurations With Different Methods · NA · unknown
- NCT06275243 — Polymorphism of ApoE in Alzheimer's Disease: Genetic Study in Castile and Leon (Spain) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03605407 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad de León
- Last refreshed: 28 January 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03605407.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing